In this Issue:
Gray matter volume in the left middle temporal gyrus as a candidate biomarker for schizophrenia
Deficits in facial emotion identification in psychosis
Metabolic effects of aripiprazole, quetiapine and ziprasidone
Modulation of mutant mGlu1 receptors derived from GRM1 mutations
Metacognitive training for schizophrenia
IL-6 and CRP levels in childhood and depression and psychosis in young adult life
Cardiometabolic risk in first-episode schizophrenia
Duration of untreated psychosis & course of schizophrenia
ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia
Maternal CRP and schizophrenia
Please login below to download this issue (PDF)